BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 31790140)

  • 1. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
    Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
    J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA Meg3 Regulates Mafa Expression in Mouse Beta Cells by Inactivating Rad21, Smc3 or Sin3α.
    Wang N; Zhu Y; Xie M; Wang L; Jin F; Li Y; Yuan Q; De W
    Cell Physiol Biochem; 2018; 45(5):2031-2043. PubMed ID: 29529600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA XIST facilitates cell growth, migration and invasion via modulating H3 histone methylation of DKK1 in neuroblastoma.
    Zhang J; Li WY; Yang Y; Yan LZ; Zhang SY; He J; Wang JX
    Cell Cycle; 2019 Aug; 18(16):1882-1892. PubMed ID: 31208278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
    Zhang KJ; Tan XL; Guo L
    Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
    Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
    J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressive lncRNA MEG3 binds to EZH2 and enhances CXCL3 methylation in gallbladder cancer.
    Li DQ; Ding YR; Che JH; Su Z; Yang WZ; Xu L; Li YJ; Wang HH; Zhou WY
    Neoplasma; 2022 May; 69(3):538-549. PubMed ID: 35188401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
    Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2.
    Han H; Wang S; Meng J; Lyu G; Ding G; Hu Y; Wang L; Wu L; Yang W; Lv Y; Jia S; Zhang L; Ji J
    Oncogene; 2020 Oct; 39(42):6513-6528. PubMed ID: 32901105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
    Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer.
    Jin L; Cai Q; Wang S; Wang S; Mondal T; Wang J; Quan Z
    Cell Death Dis; 2018 Oct; 9(10):1017. PubMed ID: 30282996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
    Zhou YJ; Yang HQ; Xia W; Cui L; Xu RF; Lu H; Xue Z; Zhang B; Tian ZN; Cao YJ; Xing ZY; Yin S; He XZ
    Life Sci; 2017 Dec; 190():7-14. PubMed ID: 28943214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ropivacaine suppresses the progression of renal cell carcinoma through regulating the lncRNA RMRP/EZH2/CCDC65 axis.
    Xiong Y; Zheng X; Deng H
    Daru; 2024 Jun; 32(1):121-132. PubMed ID: 38008820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
    Chen XJ; An N
    J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells.
    Xiao Q; Zheng F; Tang Q; Wu JJ; Xie J; Huang HD; Yang XB; Hann SS
    Cell Physiol Biochem; 2018; 49(4):1615-1632. PubMed ID: 30223276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
    Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
    Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
    Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
    Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.